Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323339294> ?p ?o ?g. }
- W4323339294 endingPage "e44491" @default.
- W4323339294 startingPage "e44491" @default.
- W4323339294 abstract "Background The pan-European VACCELERATE network aims to implement the first transnational harmonized and sustainable vaccine trial Volunteer Registry, being a single entry point for potential volunteers of large-scale vaccine trials across Europe. This work exhibits a set of harmonized vaccine trial–related educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network. Objective This study primarily aimed to design and develop a standard toolkit to increase positive attitudes and access to trustworthy information for better access and increased recruitment to vaccine trials for the public. More specifically, the produced tools are focused on inclusiveness and equity, and are targeting different population groups, including underserved ones, as potential volunteers for the VACCELERATE Volunteer Registry (older individuals, migrants, children, and adolescents). The promotional and educational material is aligned with the main objectives of the Volunteer Registry to increase public literacy and awareness regarding vaccine-related clinical research or trials and trial participation, including informed consent and legal issues, side effects, and frequently asked questions regarding vaccine trial design. Methods Tools were developed per the aims and principles of the VACCELERATE project, focusing on trial inclusiveness and equity, and are adjusted to local country-wise requirements to improve public health communication. The produced tools are selected based on the cognitive theory, inclusiveness, and equity of differently aged and underrepresented groups, and standardized material from several official trustworthy sources (eg, COVID-19 Vaccines Global Access; the European Centre for Disease Prevention and Control; the European Patients’ Academy on Therapeutic Innovation; Gavi, the Vaccine Alliance; and the World Health Organization). A team of multidisciplinary specialists (infectious diseases, vaccine research, medicine, and education) edited and reviewed the subtitles and scripts of the educational videos, extended brochures, interactive cards, and puzzles. Graphic designers selected the color palette, audio settings, and dubbing for the video story-tales and implemented QR codes. Results This study presents the first set of harmonized promotional and educational materials and tools (ie, educational cards, educational and promotional videos, extended brochures, flyers, posters, and puzzles) for vaccine clinical research (eg, COVID-19 vaccines). These tools inform the public about possible benefits and disadvantages of trial participation and build confidence among participants about the safety and efficacy of COVID-19 vaccines and the health care system. This material has been translated into several languages and is intended to be freely and easily accessible to facilitate dissemination among VACCELERATE network participant countries and the European and global scientific, industrial, and public community. Conclusions The produced material could help fill knowledge gaps of health care personnel, providing the appropriate future patient education for vaccine trials, and tackling vaccine hesitancy and parents’ concerns for potential participation of children in vaccine trials." @default.
- W4323339294 created "2023-03-08" @default.
- W4323339294 creator A5000969347 @default.
- W4323339294 creator A5005303410 @default.
- W4323339294 creator A5005524039 @default.
- W4323339294 creator A5007857954 @default.
- W4323339294 creator A5008211360 @default.
- W4323339294 creator A5008616618 @default.
- W4323339294 creator A5008626929 @default.
- W4323339294 creator A5008895379 @default.
- W4323339294 creator A5009490514 @default.
- W4323339294 creator A5009968617 @default.
- W4323339294 creator A5010180378 @default.
- W4323339294 creator A5010254315 @default.
- W4323339294 creator A5015332236 @default.
- W4323339294 creator A5017183091 @default.
- W4323339294 creator A5019173216 @default.
- W4323339294 creator A5019663284 @default.
- W4323339294 creator A5021195498 @default.
- W4323339294 creator A5025303644 @default.
- W4323339294 creator A5026731919 @default.
- W4323339294 creator A5030839688 @default.
- W4323339294 creator A5031380809 @default.
- W4323339294 creator A5032538076 @default.
- W4323339294 creator A5034878566 @default.
- W4323339294 creator A5037930524 @default.
- W4323339294 creator A5038210981 @default.
- W4323339294 creator A5044179986 @default.
- W4323339294 creator A5050402767 @default.
- W4323339294 creator A5051661862 @default.
- W4323339294 creator A5053602144 @default.
- W4323339294 creator A5054379072 @default.
- W4323339294 creator A5054863331 @default.
- W4323339294 creator A5055187048 @default.
- W4323339294 creator A5056215610 @default.
- W4323339294 creator A5056337929 @default.
- W4323339294 creator A5056345427 @default.
- W4323339294 creator A5061515151 @default.
- W4323339294 creator A5064519081 @default.
- W4323339294 creator A5068822040 @default.
- W4323339294 creator A5069099276 @default.
- W4323339294 creator A5070836704 @default.
- W4323339294 creator A5071501768 @default.
- W4323339294 creator A5072161511 @default.
- W4323339294 creator A5073654506 @default.
- W4323339294 creator A5075210419 @default.
- W4323339294 creator A5076813087 @default.
- W4323339294 creator A5078682648 @default.
- W4323339294 creator A5078861544 @default.
- W4323339294 creator A5080120008 @default.
- W4323339294 creator A5080419759 @default.
- W4323339294 creator A5084787800 @default.
- W4323339294 creator A5085951006 @default.
- W4323339294 creator A5087790746 @default.
- W4323339294 creator A5091212471 @default.
- W4323339294 date "2023-04-03" @default.
- W4323339294 modified "2023-10-17" @default.
- W4323339294 title "Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit" @default.
- W4323339294 cites W2039452393 @default.
- W4323339294 cites W2080515294 @default.
- W4323339294 cites W2084518431 @default.
- W4323339294 cites W2158780777 @default.
- W4323339294 cites W2238586764 @default.
- W4323339294 cites W2477305777 @default.
- W4323339294 cites W2900471836 @default.
- W4323339294 cites W2999496078 @default.
- W4323339294 cites W3020109684 @default.
- W4323339294 cites W3030381264 @default.
- W4323339294 cites W3041311242 @default.
- W4323339294 cites W3043403335 @default.
- W4323339294 cites W3044291841 @default.
- W4323339294 cites W3048760220 @default.
- W4323339294 cites W3086309603 @default.
- W4323339294 cites W3097590906 @default.
- W4323339294 cites W3137768732 @default.
- W4323339294 cites W3158180684 @default.
- W4323339294 cites W3169682959 @default.
- W4323339294 cites W3169783380 @default.
- W4323339294 cites W3172280019 @default.
- W4323339294 cites W3175251335 @default.
- W4323339294 cites W3201541736 @default.
- W4323339294 cites W4205472032 @default.
- W4323339294 cites W4234593333 @default.
- W4323339294 cites W4281947035 @default.
- W4323339294 cites W4290805617 @default.
- W4323339294 cites W4293572593 @default.
- W4323339294 doi "https://doi.org/10.2196/44491" @default.
- W4323339294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36878478" @default.
- W4323339294 hasPublicationYear "2023" @default.
- W4323339294 type Work @default.
- W4323339294 citedByCount "0" @default.
- W4323339294 crossrefType "journal-article" @default.
- W4323339294 hasAuthorship W4323339294A5000969347 @default.
- W4323339294 hasAuthorship W4323339294A5005303410 @default.
- W4323339294 hasAuthorship W4323339294A5005524039 @default.
- W4323339294 hasAuthorship W4323339294A5007857954 @default.
- W4323339294 hasAuthorship W4323339294A5008211360 @default.
- W4323339294 hasAuthorship W4323339294A5008616618 @default.